Snake venom enzyme could boost stroke recovery in rare brain clot study

This study tests whether adding batroxobin, a snake venom enzyme that dissolves clots, to standard blood thinners helps people with acute cerebral venous thrombosis (a rare stroke caused by a clot in a brain vein). Seventy-two adults will be randomly assigned to receive either standard anticoagulation alone or anticoagulation plus batroxobin. The main goal is to see if more patients achieve complete clot clearance within 7 days with the combination therapy.